Since the onset of the COVID-19 pandemic, national vaccination rates have dropped significantly, and there is concern about a potential rise in vaccine-preventable diseases (VPDs), especially in children. As members of the healthcare community, eye care providers should recognize that vaccines are the best way to protect themselves and their families, as well as their patients and coworkers. This webinar focuses on various systemic and ocular presentations of infectious diseases, with a focus on VPDs and public health concerns over COVID-19.
Upon completion of this course, participants will be able to:
Provided by Evolve Medical Education
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Evolve is an approved COPE Administrator.
This course is COPE approved for 1.5 hours of CE Credit for Optometrists.
Course ID: 70254-SD
Activity #: 120625
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Recommended internet speed 5Mbps+
Paula McDowell, OD, FAAO
Chief of Pediatrics
Pediatric Residency Supervisor
Michigan College of Optometry
Ferris State University
Big Rapids, Michigan
Alexandra Williamson, OD, FAAO, FCLSA
Department of Ophthalmology
Cole Eye Institute
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Dr. McDowell has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Grant/Research Support: National Institutes of Health.
Dr. Williamson has no financial relationships with commercial interests.
Editorial Support Disclosures:
Erin K. Fletcher, MIT, director of compliance and education, and Cassandra Richards, director of education development, have no financial relationships with commercial interests. Angela K. Shen, ScD, MPH, and Nisha Mukherjee, MD, peer reviewers, have no financial relationships with commercial interests.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve.